top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY:DHR)

198.87 +4.09 (+2.10%)
Streaming Delayed Price Updated: 2:15 PM EDT, Aug 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
Here's Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity ↗
The company delivered a mixed earnings report, but the sell-off looks like an overreaction. 
Via The Motley Fool
Topics Earnings
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
Danaher (DHR) Q2 2026 Earnings Call Transcript ↗
Non-respiratory growth accelerated 150 basis points as life sciences recovered. 
Via The Motley Fool
Topics Earnings
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below. ↗
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Why Danaher (DHR) Shares Are Falling Today
What Happened? Shares of diversified science and technology company Danaher (NYSE:DHR) fell 13.3% in the morning session after it reported underwhelming seco... 
Via StockStory
Gapping S&P500 stocks in Tuesday's session ↗
Via Chartmill
News headline image
Danaher Q2 Earnings Call Highlights ↗
Danaher (NYSE:DHR) reported better-than-expected second-quarter 2026 results, with management citing accelerating core revenue growth, stronger life sciences demand and benefits from productivity... 
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
Transcript: Danaher Q2 2026 Earnings Conference Call ↗
Danaher (NYSE:DHR) released second-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call... 
Via Benzinga
Topics Earnings
Get insights into the top movers in the S&P500 index of Tuesday's pre-market session. ↗
Via Chartmill
News headline image
Danaher (NYSE:DHR) Posts Better-Than-Expected Sales In Q2 CY2026 But Stock Drops
Diversified science and technology company Danaher (NYSE:DHR) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 5.5% year... 
Via StockStory
News headline image
Danaher Could Swing Over $7 Billion in Value After Earnings ↗
Earnings are back in focus on Tuesday, with a Benzinga-selected slate including Danaher Corp. (NYSE:DHR). Options pricing reveals traders are bracing for volatility, with Annaly Capital Management... 
Via Benzinga
News headline image
Danaher (DHR) Q2 Earnings Report Preview: What To Look For
Diversified science and technology company Danaher (NYSE:DHR) will be reporting results this Tuesday before market hours. Here’s what you need to know. Danah... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Cash-Producing Stock with Competitive Advantages and 2 We Brush Off
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
News headline image
Danaher (DHR) Stock Is Up, What You Need To Know
What Happened? Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 2.8% in the morning session after its recently acquired subsidi... 
Via StockStory
News headline image
3 Healthcare Stocks with Questionable Fundamentals
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have realiz... 
Via StockStory
News headline image
Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for? ↗
The life sciences giant is transforming its diagnostics segment with its acquisition of Masimo Corporation, shifting from traditional laboratory testing into patient-connected, real-time data streams. 
Via The Motley Fool
Topics Artificial Intelligence Earnings Intellectual Property
News headline image
1 Profitable Stock with Promising Prospects and 2 That Underwhelm
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
The Best Stocks to Invest $1,000 in Right Now ↗
Exploring some of the top bargains in a multi-trillion-dollar industry. 
Via The Motley Fool
News headline image
Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
From Masimo
Via Business Wire
News headline image
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
News headline image
3 Reasons to Avoid DHR and 1 Stock to Buy Instead
Danaher has gotten torched over the last six months - since December 2025, its stock price has dropped 21.2% to $178.42 per share. This may have investors wo... 
Via StockStory
Stay informed with the top movers within the S&P500 index on Thursday. ↗
Via Chartmill
Gapping S&P500 stocks in Thursday's session ↗
Via Chartmill
News headline image
SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools
From SCIEX
Via Business Wire
News headline image
SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations
From SCIEX
Via Business Wire
News headline image
Research Tools & Consumables Stocks Q1 Results: Benchmarking Danaher (NYSE:DHR)
Looking back on research tools & consumables stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Danaher (NYSE:DHR) and its p... 
Via StockStory
Topics Economy
News headline image
3 Profitable Stocks We’re Skeptical Of
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page